FDA inspection
Catalent Pharma Solutions, LLC: FDA inspection ending Dec 17, 2025
FDA inspection 1297392 · No Action Indicated (NAI) · Philadelphia, PA
Key facts
| Inspection ID | 1297392 |
|---|---|
| Firm | Catalent Pharma Solutions, LLC |
| FEI number | 3007617094 |
| Address | 10381 Decatur Rd |
| City | Philadelphia |
| State | PA |
| ZIP | 19154 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Dec 17, 2025 |
| Classification | No Action Indicated (NAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data